Background
==========

Despite being a highly vascularized organ, the thyroid gland is an unusual site of clinically detectable cancer metastasis. According to reports, the incidence of intrathyroid metastases (ITM) in autopsy series varies from 1.25% to 24.0% in cancer patients \[[@B1],[@B2]\].The most frequently noted primary sites are the kidney, breast, and lung \[[@B3]-[@B6]\]. The metastatic spread of gastrointestinal malignancies to the thyroid gland is relatively rare, and the majority come from the colo-rectum \[[@B7]\]. ITM originating from the alimentary tract are quite unusual based on our previous experience. In clinical practice, metastatic involvement of the thyroid is usually characterized by an indolent growth pattern, which results in few visible indications of the illness and difficulty in making a differential diagnosis from other primary thyroid neoplasms \[[@B8]\]. Thyroid metastasis from the esophagus has only been reported in four cases in the English literature \[[@B9]-[@B12]\]. Herein, a further case is reported of metastasis of esophageal carcinoma to the thyroid, which was misdiagnosed in the first place as primary thyroid carcinoma with unilateral lymph node metastasis, and a systematic literature review shows that this is the first case of this rare condition to be described in eastern China.

Case presentation
=================

In July 2011, a 61-year-old man presented to our department complaining of dyspnea, mild dysphagia and hoarseness for a few months with exacerbation for 10 days. There was no remarkable past medical, surgical, or family history. On admission, a large nodular mass on the left lobe of the thyroid was readily recognizable and was irregular, hard, immobile and painless on palpation. Thyroid sonogram findings demonstrated a 6.1 cm × 3.9 cm mass in the left lobe with low and heterogeneous echo and an enlarged cervical lymph node measuring 2.5 cm × 1.8 cm on the left side of the neck in the level-III region with hypoechogenicity. Fine-needle aspiration cytology of the thyroid disclosed diffuse infiltration of atypical cells with a high suspicion of malignancy, therefore the patient was scheduled for surgery.

Chest radiography and laboratory examinations including thyroid hormone showed no abnormal findings. Blood calcium level was also checked for the possibility of medullary thyroid cancer, and was within normal limits. Neck contrast-enhanced computed tomography revealed a mass encasing the left carotid sheath vessels, esophagus, and trachea in the left thyroid lobe (Figure [1](#F1){ref-type="fig"}). The man underwent bilateral near-total thyroidectomy and tracheostomy for palliative purposes because adhesions to adjacent structures and the aggravation of dyspnea were observed pre- and intra-operatively. Histological examination from the resected specimen verified moderate differentiated squamous cell carcinoma (SCC) of the thyroid gland (Figure [2](#F2){ref-type="fig"}) with metastasis to the level-III region of the left cervical lymph nodes and characteristics similar to the esophageal lesions. Further workup with introscopy biopsy revealed a squamous cell carcinoma of the distal esophagus (Figure [3](#F3){ref-type="fig"}). One month post surgery, the patient started chemotherapy with a docetaxel and cisplatin (DC) regimen, and radiotherapy according to the 2011 National Comprehensive Cancer Network (NCCN) Esophageal Cancer Guidelines. Although the patient's condition was kept under control initially, after five cycles of chemotherapy, his illness grew worse as the cancer disseminated to the peritoneal and mediastinal lymph nodes. Finally, eleven months after the diagnosis of metastasis, the patient died due to advanced esophageal carcinoma complicated by pneumonia and sepsis.

![Neck contrast-enhanced computed tomography reveals a mass encasing the left carotid sheath vessels, esophagus, and trachea in the left thyroid lobe.](1477-7819-12-106-1){#F1}

![**Multi-focal nests of tumors cells are distributed nearby the follicles.** Hematoxylin and eosin staining, ×100.](1477-7819-12-106-2){#F2}

![**Tumor cells originate from the esophagus.** Hematoxylin and eosin staining, ×200.](1477-7819-12-106-3){#F3}

Discussion
==========

The incidence of metastatic spread of gastrointestinal malignancies to the thyroid gland is relatively low and most of them are from the colo-rectum \[[@B7]\]. ITM originating from the gastro-esophagus is poorly documented. A review of the English-language literature, searching for patients with secondary cancerous growth in the thyroid formed by transmission of tumor cells from primary esophageal and gastric carcinoma disclosed a total of four \[[@B9]-[@B12]\] and five reported cases \[[@B7],[@B13]-[@B16]\], respectively. This article presents an additional case of thyroid metastasis from esophageal carcinoma occurring in a Chinese man and reviews the related references.

Table [1](#T1){ref-type="table"} summarizes the clinical circumstances for the nine cases previously published plus our report of thyroid metastasis from esophageal cancer. The age of the five female and five male patients at presentation was variable, ranging from 32 to 74 years with an average age of 61.5 years. The majority of patients underwent thyroidectomy (specific types of surgery are presented in Table [1](#T1){ref-type="table"}: this was unknown in four cases). In the postoperative histopathological specimen, there were four patients whose thyroid cancer seeded from squamous cell carcinoma, two originated from the undifferentiated carcinoma with signet-ring cells, two were derived from poorly differentiated carcinoma with characteristics similar to the gastric lesions, and the remaining cases were from poorly differentiated adenocarcinomas. Of the patients with thyroid metastasis, most had a poor outcome and died shortly after the original diagnosis (specific survival times are presented in Table [1](#T1){ref-type="table"}).

###### 

Clinical data of patients with metastatic involvement of the thyroid

  **Source**                                  **Age (yr)**   **Sex**   **Site of primary lesion**   **Type of secondary thyroid surgery**               **Pathology results from thyroid specimen**              **Outcomes (months)\***
  ------------------------------------------ -------------- --------- ---------------------------- ---------------------------------------- ------------------------------------------------------------------- -------------------------
  Present case                                     61           M              Esophagus            Palliative bilateral NT + tracheostomy                                  SCC                                            11
  Shuangshoti S *et al*. 1982 \[[@B9]\]            58           M              Esophagus                     TT + ipsilateral CL                                            SCC                                             5
  Yamada T *et al*. 1999 \[[@B10]\]                74           F              Esophagus                      ST + Bilateral CL                                             SCC                                             /
  Basu S *et al*. 2005 \[[@B11]\]                  55           F              Esophagus                              NA                                                    SCC                                            NA
  Cumbo-Nacheli G *et al*. 2007 \[[@B12]\]         32           M              Esophagus                              NA                                   Poorly differentiated adenocarcinoma                            NA
  Yoshida A *et al*. 1989 \[[@B7]\]                71           M               Stomach                               ST                                   Poorly differentiated adenocarcinoma                             7
  Ok E *et al*. 2000 \[[@B13]\]                    60           F               Stomach                          Bilateral ST                       Undifferentiated carcinoma (with signet-ring cells)                    1.5
  Lee HC *et al*. 2010 \[[@B15]\]                  71           M               Stomach                          Bilateral NT                                 Poorly differentiated carcinoma                               4
  Ihn MH *et al*. 2009 \[[@B14]\]                  63           F               Stomach                               NA                            Undifferentiated carcinoma (with signet-ring cells)                     6
  Poiana C *et al*. 2011 \[[@B16]\]                70           F               Stomach                               NA                     Poorly differentiated neuroendocrine carcinoma (with small cells)             NA

\*Follow up since diagnosis of intrathyroid metastases; NA, no data available; NT, near-total thyroidectomy; ST, subtotal thyroidectomy; TT, total thyroidectomy; CL, cervical lymphadenectomy.

Table [2](#T2){ref-type="table"} summarizes the diagnosis of thyroid cancer for reported cases. Three patients had multifocal or widespread masses and all the others had only a solitary mass. Five patients were confirmed with unilateral or bilateral cervical lymph nodes metastases and two patients had no evidence of cervical lymphadenopathy (there was no reference to this for the remaining cases. Several patients received additional examinations (specific investigations are presented in Table [2](#T2){ref-type="table"}).

###### 

The diagnosis of thyroid cancer for reported cases

  **Source**                                  **Tumor size (cm)**   **Ultrasound description**   **Extent of metastatic thyroid gland involvement**     **Cervical lymph nodes metastasis**
  ------------------------------------------ --------------------- ---------------------------- ---------------------------------------------------- -----------------------------------------
  Present case                                     6.1 × 3.9        Heterogeneous, hypo-echoic                Left lobe, solitary mass                         Left level-III region
  Shuangshoti S *et al*. 1982 \[[@B9]\]            1.5 × 1.5                    NA                           Right lobe, solitary mass                  Right level-II, −III and -IV region
  Yamada T *et al*. 1999 \[[@B10]\]                   NA                    Calcified                     Widespread masses; not specified            Bilateral level-II, −III and -IV region
  Basu S *et al*. 2005 \[[@B11]\]                    6 × 4            Irregular, hypo-echoic                 Right lobe, solitary mass                    Right level-III and -IV region
  Cumbo-Nacheli G *et al*. 2007 \[[@B12]\]         2.5 × 2.8                    NA                           Right lobe, solitary mass                  Right level-II, −III and -IV region
  Yoshida A *et al*. 1989 \[[@B7]\]                 10 × 4                      NA                    Left lobe and the isthmus, solitary mass                No evidence of disease
  Ok E *et al*. 2000 \[[@B13]\]                      4 × 5                      NA                           Right lobe, solitary mass                        No evidence of disease
  Lee HC *et al*. 2010 \[[@B15]\]                     NA                        NA                          Bilateral, multifocal masses                                NA
  Ihn MH *et al*. 2009 \[[@B14]\]                     NA                Diffuse, enlarged                 Widespread masses; not specified                              NA
  Poiana C *et al*. 2011 \[[@B16]\]                   NA                        NA                    Left lobe and the isthmus, solitary mass                No evidence of disease

NA, no data available.

Generally, despite being second only to the adrenal glands as the most vascular perfused organ in the body \[[@B17]\], the thyroid is rarely considered to be the sole site of metastases in the clinical setting and is usually asymptomatic \[[@B8],[@B18]\]. Cichon *et al.* reported that metastasis to the thyroid only accounts for 2% to 3% of all thyroid carcinomas identified in the clinical setting \[[@B19]\]. The most common primary sites are the kidney, breast, and lung (see related references \[[@B3]-[@B6]\]). To the best of our knowledge there is little information to date in the English literature about thyroid metastasis from the esophagus, except for four published cases \[[@B9]-[@B12]\].

One question is raised by our case: how to prove that the SCC of the thyroid in our patient originated from a primary esophageal carcinoma? In general, it is difficult and challenging to accurately distinguish between primary and secondary neoplasm in the thyroid. Primary SCC rarely arise from the thyroid gland, especially in older patients with a long-standing history of goître \[[@B20],[@B21]\]. The etiology remains mysterious and unclear, and presumed to originate from the metaplastic glandular epithelium. Fine-needle aspiration cytology is often used to obtain tissues for diagnosis. Nevertheless, its value in the discrimination between primary and metastatic thyroid malignancies is still uncertain when highly anaplastic cells are observed microscopically \[[@B2]\]. Our patient had no particular history of thyroid disease and the thyroid mass grew rapidly in a few months. What is more, the patient suffered an exacerbation of dyspnea. An urgent thyroidectomy was necessary to relieve threatening airway obstruction caused by tracheal compression. Postoperative histopathological examination revealed multi-focal lesions with similar pathological profiles to the esophageal lesions. Thorough work up reavealed a squamous carcinoma of the distal esophagus on esophagogastroduodenoscopy biopsy. Other findings included: dysphagia, dyspnea, hoarseness, vascular infiltration of SCC under the microscope, and some imaging observations. It was therefore confirmed as a primary esphageal cancer with metastasis to the thyroid.

Direct extension of adjacent primaries, a hematogenous pathway and lymphatic route for metastatic spread to the thyroid have been suggested \[[@B11],[@B22]\]. Czech *et al.* suggested that the vertebral vein plexus may play an important role in the process of metastases from other organs to the thyroid \[[@B5]\]. Unfortunately, according to a review of the related literature, there is no reported case of careful imaging and pathologic evaluation of the most likely route of metastasis in the thyroid. Our patient was supposed to have lymphogenous metastasis in view of unilateral lymphadenopathy and the obvious peritoneal and mediastinal lymphatic vessel infiltration.

The main method of treatment for metastatic thyroid cancers usually involves radiotherapy and surgery \[[@B8],[@B11],[@B17],[@B23]\]. The role of radiation therapy is still controversial because thyroid metastases are mainly revealed as highly anaplastic carcinomas and are usually radiation-resistant, and are often rapidly fatal. Furthermore, until recently there has been no clear consensus on the election of surgical means for metastatic thyroid cancers \[[@B5],[@B7],[@B24]\]. Sadly, thyroidectomy had no remarkably beneficial effects on the outcome of our patient. On the whole, thyroid metastasis from esophageal cancer shows a poor prognosis, with reported 9-month survival after diagnosis \[[@B25]\].

Conclusion
==========

This case highlights the need for an awareness of the possibility of potential metastatic deposits in unexpected sites. A new thyroid mass with dysphagia appearing in a patient, however remote, should be evaluated for the possibility of metastasis. Whenever the histology is unusual for a thyroid primary, metastasis should be strongly considered. Although the prognosis of metastasis in the thyroid is commonly poor, patients with a single infiltrating thyroid mass may have improved quality of life and longer survival time after accurate diagnosis and proper treatment.
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